G5-CD40 Citations (2)

Originally described in: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
Pasqual G, Chudnovskiy A, Tas JMJ, Agudelo M, Schweitzer LD, Cui A, Hacohen N, Victora GD Nature. 2018 Jan 25;553(7689):496-500. doi: 10.1038/nature25442. Epub 2018 Jan 17. PubMed Journal

---

Articles Citing G5-CD40

Articles
A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy. Mamuti M, Wang Y, Zhao YD, Wang JQ, Wang J, Fan YL, Xiao WY, Hou DY, Yang J, Zheng R, An HW, Wang H. Adv Mater. 2022 Jun;34(24):e2109432. doi: 10.1002/adma.202109432. Epub 2022 May 12. PubMed
NUPA10hd-immortalized and genetically engineered progenitors allow studying dendritic cell immune functions. Samson GPB, Anslinger N, Legler DF, Finke D. Front Immunol. 2025 Sep 1;16:1658429. doi: 10.3389/fimmu.2025.1658429. eCollection 2025. PubMed

If you have published an article using this material, please email us at to have your article added to this page.